With this key development, Kraig Labs is accelerating its production growth, positioning the Company to execute its ambitious ...

Recover Red, a leader in advanced wellness technology, has launched the PEMF+ Grounding Mat, a next-generation therapy device ...

The Phase 1 trial of PLN-101095 is currently enrolling the fourth of five potential cohorts. The fourth cohort is evaluating ...

Alpha Bites Gummies are designed for men seeking to enhance their vitality, stamina, and performance naturally and ...

Celex Oncology’s first attendance at Bio-Europe Spring 2025 follows their recent win at the 2024 EIT Health Catapult ...

Michael Young, Chairman of Better Choice, commented, “This unique royalty distribution plan underscores Better Choice’s commitment to delivering long-term value to our shareholders from our Halo brand ...

Genmab A/S (Nasdaq: GMAB) announced today updated data from cohort B1 of the Phase 1/2 RAINFOL-01 study of rinatabart sesutecan (Rina-S ®), an investigational folate receptor-alpha (FRα)-targeted, ...

The new non-executive employee received an option to purchase 35,000 shares of Annexon common stock. The option carries a ten-year term and an exercise price per share equal to $2.60, which was the ...

OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its partnership with the ...

“This new loan financing strengthens our financial position, providing additional support for developing Mother Bracelet,” said Koji Eguchi, Chief Executive Officer of MEDIROM.

Hyperfine, Inc. sold nine commercial Swoop® systems in the fourth quarter of 2024, compared to seven in the fourth quarter of 2023. Gross margin for the fourth quarter of 2024 was $0.8 million, ...

Under the terms of the new Contract Manufacturing Agreement, effective as of March 17, 2025, AVITA Medical is to manufacture PermeaDerm at its state-of-the-art manufacturing facility in Ventura, ...